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Summary  
 
Social phobia is increasingly recognized as a prevalent and socially impairing mental disorder. 
However, little data is available regarding the general and disease-specific impairments and disabilities 
associated with social phobia. Furthermore, most studies have not controlled for the confounding 
effects of comorbid conditions. This study investigates: (a) the generic quality of life; (b) work 
productivity; and, (c) various other disorder-specific social impairments in current cases with pure (n = 
65), comorbid (n = 51) and subthreshold (n = 34) DSM-IV social phobia as compared to controls with 
no social phobia (subjects with a history of herpes infections). Social phobia cases reported a mean 
illness duration of 22.9 years with onset in childhood or adolescence. Current quality of life, as 
assessed by the SF-36, was significantly reduced in all social phobia groups, particularly in the scales 
measuring vitality, general health, mental health, role limitations due to emotional health, and social 
functioning. Comorbid cases revealed more severe reductions than pure and subthreshold social 
phobics. Findings from the Liebowitz self-rated disability scale indicated that: (a) social phobia affects 
most areas of life, but in particular education, career, and romantic relationship; (b) the presence of 
past and current comorbid conditions increases the frequency and severity of disease-specific 
impairments; and, (c) subthreshold social phobia revealed slightly lower overall impairments than 
comorbid social phobics. Past-week work productivity of social phobics was significantly diminished 
as indicated by: (a) a three-fold higher rate of unemployed cases; (b) elevated rates of work hours 
missed due to social phobia problems; and (c) a reduced work performance. Overall, these findings 
underline that social phobia in our sample of adults, whether comorbid, subthreshold, or pure was a 
persisting and impairing condition, resulting in considerable subjective suffering and negative impact 
on work performance and social relationships. The current disabilities and impairments were usually 
less pronounced than in the past, presumably due to adaptive behaviors in life style of the respondents. 
Data also confirmed that social phobia is poorly recognized and rarely treated by the mental health 
system.    
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Introduction  
 
Social phobia (also known as social anxiety disorder) has recently been shown to be a 
relatively frequent, though often unrecognized and untreated disorder in the general 
population [1-6]. Considerable uncertainty still exists as to whether social phobia should be 
considered to be a ‘serious’ mental disorder per se from a public health perspective in terms 
of resulting impairments and disabilities. Although there is some evidence that patients who 
seek treatment frequently suffer a considerable degree of disability as well as a reduced 
quality of life [23, 28], such studies have neither been able to paint a complete picture of the 
impairments associated with social phobia, nor to determine the degree to which these 
impairments are due to social phobia per se, rather than to the presence of other mental 
disorders present in these patients. This latter consideration is of key importance because 
there is overwhelming evidence that comorbidity is extremely frequent among subjects with 
social phobia. Several clinical and epidemiological studies have demonstrated significantly 
elevated odds that social phobics also have other anxiety disorders, depressive as well as 
substance-use disorder [2, 6, 11, 29].  
 
From retrospective evaluations, it is generally assumed that comorbid depressive disorders are 
likely to be secondary complications of social phobia [1, 29], as is the development of alcohol 
abuse [6-10, 17]. However, there have been no prospective longitudinal studies up until now, 
which have confirmed this assumption.  
 
General population studies using fairly broad and unspecific indicators of impairments and 
disability have also suggested convergently that the lifetime presence of social phobia is 
associated with a reduced work performance, a reduced social interaction, and possibly more 
school problems during adolescence [7, 16]. Although these studies do avoid the helpseeking 
effects inherent in clinical samples, they do have considerable limitations as well: (a) due to 
the lack of specific assessment instruments for social phobia-specific impairments and 
disabilities as well as of quality-of-life (QoL) measures, they have not been able to 
demonstrate in detail the range and breadth of disabilities and reduced quality of life 
associated with social phobia; and, (b) they have failed to control their findings for the effects 
of comorbid conditions. The only evidence so far that pure social phobia, uncomplicated by 
current comorbidity, is associated with considerably reduced quality of life and substantial 
disabilities, comes from a casecontrol study in 65 community respondents with pure social 
phobia [30]. The present study provides a further extension of these latter findings by 
including subthreshold and comorbid social phobia as comparison groups.  
 
Aims  
 
The primary aims of this analysis are to provide a more detailed picture of lifetime and 
current psychosocial impairments, disabilities, and handicaps associated with social phobia, as 
well as their impact on the patient’s generic quality of life. In this respect, the paper focuses 
on the following outcome measures: quality of life, lifetime and current disease-specific 
psychosocial impairments and difficulties, work productivity and health care utilization. To 
study the effects of comorbidity on these outcome measures, pure and comorbid social phobia 
(social phobia with comorbid conditions) will be compared to a control group unaffected by 
social phobia. Finally, a secondary objective of this study is to examine how subthreshold 
social phobics differ from the pure and comorbid group. Subthreshold social phobia is defined 
here as social phobia not fulfilling the DSM-III-R criterion E (‘interferes with occupational 
functioning or with usual social activities or relationships with others, or there is marked 
distress about having the fear’ APA, 1987, page 243). Interest in this issue has been 
stimulated by a recent study of Davidson et al. [7] suggesting substantial impairments even in 
subthreshold social phobics.  
 
Materials and Methods  
 
The methods of this study have already been presented elsewhere in greater detail [30]. Thus 
the sample and the procedures used will be described only briefly here.  
 
Recruitment of subjects - Inclusion and exclusion criteria  
 
In order to avoid systematic helpseeking biases (for example, patients actively seeking 
treatment might be the most severely impaired or social phobics being afraid of contacting 
personally a mental health service), study participants were recruited through advertisements 
in several local daily and weekly newspapers in the greater Munich area and thus were not 
recruited from our inpatient and outpatient units. The advertisement asked for participation of 
subjects suffering from fear or avoidance of one or more social situations, listed according to 
the stem questions of our diagnostic study instrument, the Composite International Diagnostic 
Interview (CIDI) [12, 13]. Potential subjects were encouraged to contact us by phone to 
reduce the fear of the first contact. People who responded to this announcement were then 
briefly screened by a research assistant using a checklist to assess some of the inclusion and 
exclusion criteria. They were also told that the survey was confidential and that they would be 
paid a small fee. General inclusion criteria were: an age between 18 and 60 years, 
endorsement of at least one social phobia screening item, and a duration of social phobia 
problems of at least six months. Subjects with severe visual impairment and those currently 
being treated in medical and psychiatric hospitals or other settings were also excluded. After 
this telephone screening, respondents who met the criteria for entrance into the study were 
scheduled for a detailed clinical interview at the institute.  
 
Overall 240 subjects responded to the announcement; 63 were excluded in the telephone 
screening and the remaining 177 were subselected for the personal interview. Of these, nine 
did not show up, 15 did not meet the DSM-III-R criteria for even subthreshold social phobia, 
and three did not complete all the questionnaires. Thus, 150 cases were accepted for further 
investigation, completed the study interview, and were subsequently assigned to one of the 
following social phobia comparison groups:  
 
Comparison group A: pure social phobia (n = 65)  
 
From the diagnostic interview, 65 subjects were found to have a current pure social phobia 
and no comorbidity. Thus, this group comprised only social phobics meeting criteria for 
threshold social phobia according to DSM-III-R criteria, but not for current or past major 
depression, bipolar disorder, dependence on alcohol, medication or illegal substances, 
agoraphobia, panic disorder, generalized anxiety, eating disorder, dementia or psychotic 
disorder.  
 
Comparison group B: comorbid social phobia (n = 51)  
 
This group comprised 51 comorbid subjects with current threshold social phobia according to 
the DSMIII-R criteria. All had lifetime or current diagnoses of major depression (n = 31, 
60.8%) and/or dysthymia (n = 16, 31.4%). Most had other additional lifetime diagnoses (the 
12 month comorbidity rates are reported in table II). These were found to be most frequently 
alcohol abuse or dependence (n = 20, 39.2%); agoraphobia with or without panic attacks (n = 
20, 39.2%); panic disorder (n = 18, 35.3%); generalized anxiety disorder (n = 9, 17.6%); and, 
eating disorders (n = 9, 17.6%). Four subjects had a past history of psychotic disorders, four 
fulfilled lifetime criteria for drug dependence, and four had an obsessive compulsive disorder 
(7.8%).  
 
Comparison group C: subthreshold social phobia (n = 34)  
 
Thirty-four cases met all of the current diagnostic criteria except the current 
impairment/distress criterion (E) of the DSM-III-R criteria. Eleven also had at least one other 
lifetime diagnosis (12 month comorbidity, findings are reported in table II). Three had major 
depressive episodes at some point in their lifetime, 11 had alcohol use disorders, one an eating 
disorder, two had panic with agoraphobia, and one a sedative dependence.  
 
Control group (n = 65)  
 
In order to test our social phobia group against a group of subjects who had also suffered for 
several years from a physical disease with a fluctuating course, the control group was sampled 
from an existing database of individuals with recurrent herpetic infections which matched the 
pure social phobia group by age and gender (subjects were not matched for employment and 
marital status because both variables are believed to be a potential consequence of social 
phobia). In terms of impairments and the use of the health service, this constitutes a tougher 
test as these controls could be expected to have a reduced quality of life and to use the health 
services more frequently than the general population, and healthy controls in particular. The 
controls had responded to a similar newspaper announcement in autumn 1993. Research 
assistants contacted these people to assess their willingness to participate in this new study. 
Interested subjects responding by telephone were screened and scheduled for exactly the same 
clinical assessment described below for subjects with social phobia.  
 
Characteristics of the study group  
 
Table I summarizes the sociodemographic characteristics of the four comparison groups. With 
no significant between-group differences for gender and mean age, significantly more 
subjects in the control group (56.9%) were married at the time of selection, compared with 
only 33.8% in the pure social phobia group (P < 0.05), 17.6% in the comorbid group, and 
29.4% in the subthreshold group. This difference was due to a lower number of subjects who 
had never been married and a higher number of divorced subjects in the social phobia groups. 
Social phobics were also more frequently unemployed (P < 0.05) in comparison with controls.  
 
Interviewer and instruments  
 
The face-to-face interviews were conducted by nine clinical psychologists, all of whom were 
staff members of the Clinical Institute of the Max Planck Institute of Psychiatry in Munich. 
The average clinical experience of the interviewers was 2.3 years. The interviewers were all 
trained in the use of CIDI by the first author, who directs the official World Health 
Organization Training Center for CIDI. In addition, interviewers received a one day training 
in the use of the other assessment instruments used in this study.   
 
Psychopathology and diagnostic status  
 
The Composite International Diagnostic Interview – core version 1.1 (CIDI) [12], a fully 
structured diagnostic instrument, was used to confirm the presence of social phobia in the 
study group and the absence of social phobia in controls. It was also used to determine the 
presence of lifetime and current mental disorders according to the diagnostic algorithms of the 
DSMIII- R. The CIDI version 1.1 provides both ICD-10 and DSM-III-R diagnoses. 
Throughout this paper only the DSM-III-R diagnoses will be reported. Diagnostic findings are 
reported without using diagnostic hierarchies in order to examine comorbidity. The validity, 
test-retest and inter-rater reliability [14-17] of the CIDI have been established.  
 
Quality of life  
 
As a measure of the generic quality of life the HOS-short forum (SF-36) [18, 19] was used for 
several reasons. This scale has the advantages of being brief, it can be self-administered, and 
it is comprehensive in that it measures a broad range of health concepts that are neither 
disease nor treatment-specific [18]. It also meets the psychometric standards of validity and 
reliability [19-21]. The SF-36 includes 36 items and requires approximately ten to 15 minutes 
to complete. It has been self-administered by people as young as 14 years old. The survey is 
available in several languages, including the German version used in this study [22]. SF-36 
standardized scale scores of 50 to 70 are usually regarded as indicating moderately reduced 
quality of life, whereas scores below 50 indicate a markedly reduced quality of life. These 
threshold scores were used for some of the analysis described below.  
 
Disease-specific disabilities  
 
Disease-specific disabilities were assessed by the Liebowitz Disability Self-Rating Scale 
(LDSRS), which measures life-style impairment due to emotional problems. It considers 
handicaps in the areas of education, employment, family, social and romantic relationships, as 
well as the patient’s ability to perform routine activities of daily living. The schedule consists 
of 11 items, each scored from ‘0’ (no effect) to ‘3’ (severe limitation). Evidence for the 
internal consistency and concurrent validity of the Liebowitz scale in social phobia have been 
reported [23]. In this study we compute an overall LDSRS score for the current (past four 
weeks) and worst time period (when the social phobia symptoms were worst), by taking the 
theoretical maximum score of not having any impairment as 100%. Thus a mean score of 39, 
for example, indicates substantial disabilities.  
 
Work productivity  
 
To measure work productivity, the Work Productivity and Impairment Questionnaire (WPAI) 
of Reilly et al. [24], was used to quantify the effect of general health and symptom severity on 
work productivity. Evidence of the construct validity and reproducibility of the WPAI has 
been presented. The WPAI measures the percentage of work time spent actually working, 
considering both full and part day absences. It also considers performance at work, measured 
as a percentage of maximal performance. The product of these two measures is called overall 
work productivity.  
 
Health care utilization (HSUI)  
 
In addition to information from the CIDI, the Health Service Use Inventory (HSUI) designed 
for use in clinical trials was used. It measures the number of encounters with health care 
providers during the two weeks preceding survey administration. Visits to physicians, visits to 
other practitioners, home health care visits, and inpatient and outpatient hospital stays were all 
considered.  
 
Results  
 
Clinical characteristics of social phobias  
 
Table II shows that a clear majority (61.8%) of subthreshold cases was classified as ‘isolated’ 
(predominantly performance or situational social fears only) social phobia, using CIDI 
conventions. The ‘generalized’ subtype is over-represented in both the pure (52.3%) and in 
the comorbid group (80.4%). Almost all subjects with generalized social phobia endorsed 
‘speaking fears’ items of the CIDI and at least one other item (mean number of social fears 
endorsed, pure group: 2.8; comorbid: 4.3; subthreshold: 2.2). Almost all subjects, except for 
the subthreshold group, reported severe ‘panic-like’ anxiety reactions when being confronted 
with, or thinking about being exposed to, and reported predominately persistent avoidance – 
rarely endurance in such situations. Subthreshold phobics displayed lower frequencies of 
persistent avoidance (64.7%) and severe anxiety reactions (67.6%). In agreement with 
previous findings, only few social phobia cases had contacted a doctor or other health 
specialists because of their condition. Comorbid cases (51%) had done so slightly more 
frequently than pure social phobia cases (35.4%). Even fewer cases indicated having ever 
received some type of formal treatment because of their condition (pure: 12.4%; comorbid: 
19.6%; subthreshold: 2.9%).  
 
Among comorbid cases there is a substantial degree of current (12 month) multimorbidity. 
More than two thirds in the comorbid group had at least one additional 12 months diagnosis. 
Every second person in this group was either suffering from major depression or dysthymia, 
the most frequent comorbid conditions. Close to 50% also met currently criteria for 
agoraphobia or other anxiety disorders.  
 
Separate attention should be given to substance use disorders and particularly to the use of 
nicotine and alcohol. All three groups revealed significantly increased rates of current nicotine 
dependence in comparison with the nicotine dependence prevalence in the general population 
of 29% and 27.2% in the control group. They also smoked a significantly higher number of 
cigarettes per day (control group mean: 11.2, SD: 6.4). Seventy-one percent of the pure, 
84.3% of the comorbid, and 68% of the subthreshold social phobia cases considered 
themselves as regular smokers during the 12 months prior to the interview according to the 
CIDI (control group: 32.3%). Similarly, the current (past year) average amount of alcohol 
consumed per week (measured in grams of absolute alcohol) was significantly higher in all 
three groups as compared to the control group (mean: 28.9, SD: 22.2). This remarkable 
tendency to consume alcohol is also reflected in higher rates for alcohol abuse or dependence. 
(Alcohol dependence was an exclusion criterion in the pure social phobia group).  
 
The cumulative probability curve for age of onset (figure 1) of social phobia indicates that the 
vast majority of patients in all three social phobia groups reported the onset of their anxiety in 
childhood or adolescence. At the age of 20, approximately 70% in each of three groups had 
already fulfilled the diagnostic criteria for social phobia. We also examined how frequently 
social phobia occurred after the onset of another comorbid mental disorder, by comparing the 
respondents’ retrospective age-of-onset information from the CIDI. Except for four subjects 
with dysthymia, three cases with eating disorders, and two subjects with alcohol or drug use 
disorder, all other comorbid conditions in the comorbid group were clearly secondary to 
social phobia by at least one year. An additional four subjects indicated an onset of panic 
attacks prior to the onset of social phobia; however, the onset of threshold agoraphobia or 
panic disorder was secondary.  
 
Almost all social phobia subjects could be described as chronic with a mean illness duration 
of more than 20 years. When asked at what age their social phobia symptomatology was 
worst (peak episode), the subjects indicated a mean age of 26.0 (SD = 10.0). We will 
subsequently report findings for disease-specific impairments both for the past weeks as well 
as for this peak episode when the symptomatology was worst.  
 
Current generic quality of life (QOL, SF-36)  
 
In comparison with the control group, pure social phobics revealed significantly (Wilcoxon 
signed rank test for matched groups) lower scores in several of the SF-36 scales indicating a 
reduced quality of life (figure 2). Significant (P < 0.05) reductions in self-rated quality of life 
were evident for the following scales: GHP (general health), RE (role limitations due to 
emotional problems), SF (social functioning), GMH (general mental health), and VIT 
(vitality). Subthreshold social phobics and even more comorbid social phobics revealed 
similar or even lower SF-36 mean scores than the pure social phobia group in almost all 
domains.  
 
When the respondents were sub-typed according to their standardized summed score for the 
three scales measuring the emotional health component (SF, GM, and VIT, table III), 23.1% 
of all subjects with pure social phobia, 51% of those with comorbid, and 20.6% with 
subthreshold social phobia were categorized as severely impaired (score below 50), and 
24.6%, 31.4 and 35.3% respectively, were categorized as markedly impaired. In the control 
group, by contrast, only 4.6% were either severely or markedly impaired.  
 
Thus, all three social phobia groups were significantly (P < 0.01) more impaired than the 
control group.  Taking together all moderately and severely impaired in the social phobia 
groups we can state that at least 50% of all social phobics (as compared to only 4.6% in the 
control group) had a markedly reduced quality of life. Furthermore, the comorbid group is 
significantly (P < 0.001) more impaired than both the pure as well as the subthreshold group, 
whereas no significant differences were found in the comparison between the pure and the 
subthreshold social phobia group.  
 
The degree of quality of life impairments was significantly related to the number of social fear 
situations reported (df = 8, F = 0.8, P < 0.05). It is also noteworthy that neither illness 
duration, age of onset, nor the number of depressive symptoms reported in the depression 
section of CIDI was significantly related to the SF-36 reductions.  
 
Disease-specific disabilities  
 
Figure 3 describes the subject-rated disease-specific disabilities in different domains. (We 
also used a clinicianrated version [disability profile] as well, although these findings are not 
reported here because they were almost identical). Although this scale has additional scales 
for suicidal ideation, alcohol and medication use, these three variables – consistent with 
Schneier et al. [23] – were neither used in the summary score nor reported separately in the 
figure.  
 
On most of the scales, at least 50% of respondents in each group indicated at least some 
current impairment due to their social phobia. Overall, the ratings for the ‘worst period ever’ 
as measured as a reduction of the maximum DSRS sum score of 100 (no disability), ranged 
from a low of 39.9 for comorbid social phobia to 64.7 for subthreshold, and 60 for the pure 
social phobia group. Overall, current disabilities ranged from 67.9 for comorbid, over 82 for 
pure, to 87.6 for subthreshold social phobia. This indicates that social phobics generally had 
more severe impairments when symptomatology was at its peak as compared to the current 
status (Wilcoxon rank sum test for pure group: P < 0.003, for comorbid group P < 0.001). 
This finding might suggest that many cases have suffered the most severe restrictions in the 
past and might have ‘learned’ to live and cope with at least some of the impairments.  
 
Consistent with the elevated substance use and substance use disorder rates reported above, 
the use of psychotropic substances seem to play a significant role in ‘coping’ with social 
phobia problems, as indicated by the elevated rates for moderation in alcohol use as well 
abstinence from drugs (drug findings in brackets: pure group: 0.8 [0.3], comorbid: 0.9 [0.5], 
subthreshold 0.6 [0.3], all group differences non-significant). The difference in the LDSRS 
total score between the subthreshold and the pure group was not significant. However, the 
comorbid group is significantly more impaired than the subthreshold and the pure group 
(Wilcoxon rank sum test: P < 0.01). Disabilities for pure and comorbid social phobia were 
most severe for romantic relationships, and similarly severe for educational attainment/career, 
employment (or if homemaker, household management), mood regulation, social network, 
other interests and family relations. Daily activities were least affected (current and worst). 
Consistent with this, the most severe disabilities were reported by comorbid social phobics. It 
is further noteworthy that there were – consistent with the previous findings of Weiller et al. 
[27] – remarkably high scores for the variable ‘frequent suicidal ideation/diminished desire to 
live’ (comorbid: 2.2, pure: 1.2, subthreshold: 1.2).  
 
Professional status and work productivity (WPAI)  
 
In interpreting the work productivity findings one needs to take into account that a substantial 
number of social phobics were currently unemployed (11% in the pure group, 22% in the 
comorbid group, and 12% in the subthreshold social phobia group). Most of them attributed 
the unemployment to their social phobia problems. The following WPAI findings only refer 
to those subjects who were employed or working at the time of assessment, excluding all 
homemakers and those being unemployed. Figure 3 indicates that social phobia is 
characterized by a considerable decrease in general work productivity due to illness and 
related emotional problems. Taking the WPAI overall-index for work productivity (ranging 
from 100 = completely disabled to 0 = no reduction), the pure social phobia (11.4) and the 
comorbid social phobia group (12.4) displayed a significantly higher mean WPAI index than 
the control group (1.5, P < 0.001). This can be interpreted as a 11.4 to 12.4% work 
productivity reduction. The breakdown of some selected WPAI components used in 
calculation the WPAI overall index (figure 4), suggests that this is due in all three social 
phobia groups to an elevated number of subjects reporting at least once in the past month, 
complete work loss days as well as a diminished productivity when working.  
 
Health care utilization  
 
Except for a slight but non-significant increased rate of visits to primary care providers in all 
social phobia groups as compared to the control group, no increase in current health care 
utilization was found. Although we tried to identify whether there were subgroups of social 
phobia cases with a particularly high risk of heavy utilization (comorbid vs. non-comorbid, 
those being aware of having social phobia vs. those who are not), none of these comparison 
led to different findings.  
 
Conclusion  
 
This study is the first to examine in a non-patient sample: (a) the generic quality of life as well 
as diseasespecific impairments of pure social phobics, uncomplicated by lifetime and current 
comorbid conditions; (b) differences between comorbid and pure social phobics in terms of 
the range and breadth of disabilities and the reduction in quality of life; and, (c) disabilities 
experienced by subthreshold social phobias, on the basis of standardized assessments with 
regard to diagnosis, quality of life, disease-specific disabilities as well as work productivity. 
The social phobics examined consisted predominantly of untreated cases suffering from social 
phobia over two decades. The majority were suffering from fairly ‘generalized’ social fears, 
except for the subthreshold group in which fairly isolated social phobia prevailed. The use of 
a control group of people suffering from a recurring physical disorder (herpetic infections) 
instead of a healthy control group, allowed a stringent and more difficult test of how social 
phobia affects quality of life.  
 
The study subjects were recruited through newspaper advertisement instead of sampling them 
from treatment settings, in order to avoid helpseeking selfselection biases, which might be 
considerable in treatment samples. This sampling strategy also helped to cover a broad 
spectrum of cases of various degrees of severity. In terms of the limitations of this sampling 
strategy, it needs to be mentioned that our social phobia cases might not be representative for 
social phobics in general. The ideal design would have been to use a random population 
sample – a strategy that was not feasible because of financial restrictions. Another limitations 
is that only the pure social phobia group was matched to the controls, whereas no such 
matching was feasible for the comorbid and the subthreshold group.  
 
As compared to more recent epidemiological findings in the general population, such as the 
NCS [16, 17], our social phobia cases seemed to be quite similar in terms of gender, marital 
status, professional status, age of onset, and comorbidity rates, as well as in the severity and 
current help-seeking behavior. A major apparent difference however, is the higher age in our 
sample at the time of assessment as well as the greater length of illness. Our sampling 
procedure resulted in more older subjects willing to be interviewed. In contrast, only a few 
younger subjects, with more recent onset of the disorder, responded to our advertisement. 
Thus our findings might be more characteristic for older and chronic cases with social phobia.  
 
Quality of life  
 
Compared to the controls, pure social phobics uncomplicated by comorbid conditions 
demonstrated that they experienced a highly significant reduction of current generic quality of 
life (QOL), in particular with regard to the SF-36 factors of general health, social functioning, 
general mental health, and role functioning. This was due to emotional, social phobia-related 
problems and their general health status. The clear majority of all social phobics showed at 
least marked overall impairments. Subthreshold cases did not differ in any of the scales from 
pure social phobics, whereas comorbid social phobics were significantly more affected in 
their quality of life. Remarkably, social phobia of any type examined not only revealed 
considerable reductions in those SF-36 scores that directly relate to emotional health, but also 
in those covering general health, bodily pains, and vitality. Since we found no indications of 
increased health care utilization for somatic illnesses, we have no reason to assume that social 
phobics might suffer more frequently than controls for manifest somatic illnesses. We rather 
assume that the life style of people suffering from social phobia for many years might result 
in a substantially increased risk for ill health.  
 
Given the fact the vast majority of cases were not at the peak of their illness severity at the 
time of the interview, we can assume considerably stronger reductions of quality of life, 
especially in terms of the subscales for mental health and social functioning, for more acute 
cases, than we were able to examine in this study.  
 
The overall reductions in the standardized SF-36 scores of pure social phobia are quite similar 
to those reported for depressed outpatients [25]. Comorbidity, and in particular the presence 
of depression, seems to increase considerably the degree of impairments in terms of quality of 
life. In an attempt to identify which of the characteristics of social phobia predict the degree 
of reduction in quality of life, we examined a number of clinical variables. Interestingly 
however, the number of social phobic trigger situations (isolated vs. generalized social 
phobia) was found to be the only variable significantly related to a reduction in SF-36 scores. 
Neither duration of illness, age of onset, nor the presence of a current major depression in the 
CIDI were found to be significantly related to current SF-36 scores. This would suggest that 
the number rather than the symptoms (and not only depressive symptoms alone) contribute to 
the high degree of disability observed in social phobia.  
 
Disease-specific impairments  
 
With regards to disabilities, measured by the Liebowitz Disability Self-Rating Scale 
(LDSRS), we found (as did Schneier et al. [23]), that: (a) social phobia affects most areas of 
life, but in particular romantic relations, education, career, and family relations; (b) the 
presence of past and current comorbid conditions increases considerably the frequency of 
disease-specific impairments; and, (c) that subthreshold social phobia shows only slightly 
lower overall impairment scores when compared to pure threshold social phobia. From the 
selfreported disability data, we can describe social phobics as follows. The majority are able 
to work at a job appropriate to their abilities, but they clearly perform beneath their abilities. 
They also have a clear impairment in dating activities or marital problems. They had a few 
friends they meet regularly, but this represented fewer friends than desired. The majority were 
able to participate in some non-work interest (hobbies, sports), but again, clearly less than 
desired, due to their avoidance of social activities. In family functioning and the activities of 
daily living, the group as whole experience some distress but no clear impairment of 
functioning, except for those who were unemployed. There is a markedly increased risk for 
suicidal ideation, particularly in the comorbid group.  
 
It is important to note that almost all social phobics indicated considerably higher ratings of 
impairment for the past, when their symptoms were worst. Thus, current impairments were 
usually less severe than during the peak of the illness. The peak of severity was rated by most 
to have occurred in early adulthood (when decisions had to be made relating to educational 
attainment, professional career, partnership, and friends). In many cases these individuals had 
obviously learnt to some degree to ‘live’ and ‘cope’ with some of their disabilities. Our 
findings from the LDSRS, as well as from the CIDI, suggest that alcohol use and smoking 
might play an important role in coping with social phobia problems. The rate for nicotine 
dependence was almost double the rate observed in the matched control group, and alcohol 
use disorder rates almost triple. The high risk of dependence for both substance disorders 
(20.6% fulfilled dependence criteria) in the subthreshold and the comorbid social phobia 
group (29.4%), was especially unexpected and deserves further attention in future studies.  
 
The high scores illustrating disabilities affecting partner and romantic relationships match our 
findings for the current sociodemographic status. These demonstrated a significantly lower 
percentage of subjects in all social phobia groups who were never married, as well as higher 
percentages of divorced subjects. Similarly, the disability scores in the domains of 
educational, work and career achievement parallel the finding that social phobics were more 
frequently unemployed and less frequently in the workforce, compared with both the controls 
as well as with the official unemployment statistics for this age group (German National 
Bureau of Statistics for 1994, [26], the year this study was conducted: 5.4%).   
 
Work productivity  
 
Social phobia also leads to substantial reductions in work productivity and daily life activities. 
In addition to the elevated unemployment rates, pure and comorbid social phobics were more 
frequently significantly reduced in their work productivity, as expressed by the number of 
work days missed and in impairment in work performance. As measured by the WPAI work 
productivity score, the reduction could be estimated to amount to 12% in both the pure and 
the comorbid social phobia group. Furthermore, significantly impaired activities of daily 
living measured in the WPAI underline the above mentioned findings of a reduced quality of 
life. Unlike these two social phobia groups, subthreshold social phobics revealed only minor 
reductions in work productivity.  
 
Like most recent epidemiological studies in the US (NCS) [6] and Germany [1], we found 
that only about one-third of all social phobics received some kind of treatment in the course of 
their illness. Most frequently, some kind of pharmacological intervention was reported – 
predominantly sedatives and less frequently beta-blockers – prescribed by their primary care 
doctors for at least a week. Treatments by psychiatrists were extremely rare, but treatment by 
psychologists was relatively more frequent. Although other indices of current health care use 
were examined, no clear evidence was found that social phobics, whether comorbid or not, 
used health services significantly more frequently than the matched control group. However, 
in interpreting this finding one should acknowledge that in terms of health service utilization, 
we only examined current health service utilization. We were unable to indicate whether our 
social phobics were using services more heavily in their previous illness history. Based on 
additional information about treatment history of our cases, we can assume that most social 
phobics examined, were generally not content about the treatment effects of their lifetime 
treatments, and that they remained rather pessimistic about the chances to improve their social 
phobia problems. This attitude of demoralization in all of the three groups examined might 
also explain the low current utilization rates of health care services as well as the increased 
rates of suicidal ideation.  
 
In summary, our findings show that social phobia seems to be a persisting illness, producing a 
considerable decrease in the quality of life, as well as producing numerous and considerable 
specific social role impairments and disabilities. Educational attainment, career and work 
productivity, as well as relationships with others (partner, family, friend), are the domains the 
most strongly affected. Although comorbidity seems to worsen the overall disability picture, it 
is also noteworthy that the vast majority of comorbid social phobics described their social 
phobia as the primary disorder, occurring many years before other comorbid conditions 
evolved. This might suggest that social phobia in itself might put the individual at a 
considerable longterm risk for developing depressive, substance use, and possibly other forms 
of mental disorders. In this respect, special attention should be paid to the critical role of 
nicotine and alcohol use and the subsequent development to develop substance disorders.  
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